A study of 614 fully vaccinated health workers in India found a "significant" drop in their Covid-fighting antibodies within four months of the first shot.
Remitly set terms for its IPO on Tuesday. The fintech company expects to raise $284.6 million, or $332.6 million if underwriters purchase additional shares. It will...
Are founders in fundraising mode short-sighted when it comes to working with Chinese venture funds? Runa Capital’s Asia business development manager Denis Kalinin studied data from...
Futures Coiled Ahead Of Critical CPI Print Having come dangerously close to dropping 6 days in a row, the longest streak since Feb 2020, US stock-index...
Growth in the US solar energy market is expected to skyrocket in the coming years. Get ready by checking out the top US solar energy stocks....
Oil Surges To 5 Week High As BofA Sees Crude Hitting $100 In A "Very Cold Winter" Oil rose more than 1% on Monday, supported by...
Bharat Biotech's intranasal Covid-19 vaccine candidate is expected to enter the Phase II portion of a Phase II/III study within the next few weeks. BBV154 marks the second vaccine...
A specific vertical of BNPL products is gaining traction: one targeted toward small and medium enterprises (SMEs), also known as "SME BNPL."
- by New Deal democratI have been saying for some time that the Delta wave would probably peak around Labor Day. It’s not certain yet, but...
Microsoft (MSFT) and OYO have inked a strategic partnership agreement to come up with next-generation products for the travel industry. The two are coming together to...
Check out these consumer discretionary stocks making moves this week. The post Top Consumer Discretionary Stocks To Watch In September 2021 appeared first on Stock Market...
Another cautious day in the stock market as investors await jobs data. The post Stock Market News For Today September 9, 2021 appeared first on Stock...
A seismic network was put in place after the 2010 quake but, despite recording two ‘strong motions’ before August 14, no alerts went out.
(1) This sums it all up: Today, low policy rates are no longer a countercyclical tool. Instead, they are a structural feature of the financial system....
Quinn: "This War On COVID Will Never End" Authored by Jim Quinn via The Burning Platform blog, “Do not be deceived: God cannot be mocked. A...
The livestreaming boom is driving a significant uptick in the creator economy, as a new forecast estimates consumers will spend $6.78 billion in social apps in...
The live streaming boom is driving a significant uptick in the creator economy, as a new forecast estimates consumers will spend $6.78 billion in social apps...
One of America's earliest investors in China fired an opening salvo in a potential war of words with the biggest global asset manager this week, as...
Indian drug developer Hetero received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's Covid-19 drug.
(1) Merryn Somerset Webb (MSW) does not work for FT but writes for FT. She is refreshing to read. In her understated way, she points out...
Various companies have been engaged in producing COVID-19 vaccines since the onset of the pandemic. Clinical-stage biotech firm Ocugen (OCGN) joined the race in December 2020,...
Indian logistics firm Delhivery has courted one more high-profile investor before its expected IPO in the next two quarters: Lee Fixel’s Addition. The Gurgaon-headquartered firm has disclosed...
Amidst Historic Labor Shortage, The Retail Race To Secure Tens Of Thousands Of Holiday Workers Has Officially Started On Thursday of this week Walmart decided to...
Why All The Fuss About Ivermectin? Authored by Brian C. Joondeph via AmericanThinker.com, First hydroxychloroquine, now ivermectin, is the hated deadly drug de jour, castigated by the...
India Approves World's First DNA-Based COVID Vaccine Shortly after Taiwan announced that it had successfully produced its own vaccine as it seeks to bolster its domestic...
Ocugen (OCGN) came into limelight after the company signed a deal to market Bharat Biotech's COVID-19 vaccine (Covaxin) in the United States.
Amazon Tells Contractors To Stop Screening For Marijuana As Hiring Binge Begins Both Amazon and Walmart are about to make massive pushes to add more than 55,000...
The internationally recognised composer, peace worker and musical therapy pioneer tells pharmaphorum how his emerging field stands at The post Prof Nigel Osborne: Science is catching...
GlaxoSmithKline will join the growing list of biotechs that mandate vaccinations for its US employees, and a company spokesperson said it is looking into UK policy...
If you're new to investing in gold, you may be wondering what factors influence the gold price today. Here's a quick look. The post An Overview...